Intervention not reported
Adverse events none of the studies reported on this outcome · children and adolescents aged 4 years to 18 years, with chronic musculoskeletal pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Depression none of the studies reported on this outcome · children and adolescents aged 4 years to 18 years, with chronic musculoskeletal pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Anxiety none of the studies reported on this outcome · children and adolescents aged 4 years to 18 years, with chronic musculoskeletal pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Quality of life none of the studies reported on this outcome · children and adolescents aged 4 years to 18 years, with chronic musculoskeletal pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Disability measured on CHAQ (0 to 3; 0 = no disability) Postintervention: first assessment after end of treatment; no later than 3 months · children and adolescents aged 4 years to 18 years, with chronic musculoskeletal pain
1 finding from 1 review
Intervention not reported
Adverse events none of the studies reported on this outcome · children and adolescents aged 4 years to 18 years, with chronic musculoskeletal pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Depression none of the studies reported on this outcome · children and adolescents aged 4 years to 18 years, with chronic musculoskeletal pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Anxiety none of the studies reported on this outcome · children and adolescents aged 4 years to 18 years, with chronic musculoskeletal pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Quality of life measured on multiple scales (0 to 100; higher score = better quality of life) Postintervention: first assessment after end of treatment; no later than 3 months · children and adolescents aged 4 years to 18 years, with chronic musculoskeletal pain
1 finding from 1 review
Intervention not reported
Pain intensity none of the studies reported on this outcome · children and adolescents aged 4 years to 18 years, with chronic musculoskeletal pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Disability none of the studies reported on this outcome · children and adolescents aged 4 years to 18 years, with chronic musculoskeletal pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse events none of the studies reported on this outcome · children and adolescents aged 4 years to 18 years, with chronic musculoskeletal pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adherence to inhaled therapies cMPR · children aged 5 to 16 years
Digital technology (TIM) may leads to higher adherence to the inhaled treatment: compared with standard treatment (TBM) (low certainty).
1 finding from 1 review
Pulmonary exacerbations · adults (aged 16 years and over) with CF
Digital technology (web‐based platform CFHealthHub) probably leads to lower number of pulmonary exacerbations compared with usual care (moderate certainty).
1 finding from 1 review
Treatment burden · children aged 5 to 16 years
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · children aged 5 to 16 years
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
FEV1 (% predicted): mean change from baseline · children aged 5 to 16 years
Digital technology (TIM) showed no clear difference in FEV1 (mean change from baseline, % predicted) compared with standard treatment (TBM) (low certainty).
1 finding from 1 review
Pulmonary exacerbations · children aged 5 to 16 years
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment burden · adults (aged 16 years and over) with CF
Digital technology (web‐based platform CFHealthHub) probably leads to higher treatment burden: CFQ‐R treatment burden domain score (higher score… compared with usual care (moderate certainty).
1 finding from 1 review
QoL · adults (aged 16 years and over) with CF
Digital technology (web‐based platform CFHealthHub) showed no clear difference in qoL: CFQ‐R domain scores at end of study compared with usual care (moderate certainty).
1 finding from 1 review